iHear MatriX vs Otofonix Encore

The iHear MatriX is a behind-the-ear OTC hearing aid priced at $499, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This places it in the top 40% of OTC hearing aids, offering solid performance at a budget-friendly price point. In our testing, the MatriX demonstrated notable strengths in speech intelligibility. Speech in quiet scored a solid 4.0/5, measuring 1.17 points above the category average. Speech in noise performance came in at 2.4/5—above the category average by 0.96 points, though only mixed in absolute terms. Feedback handling was excellent at 5.0/5, surpassing the already-strong category average by 0.46 points, meaning users can expect reliable stability without whistling during typical wear. The most significant limitation is music streaming, which scored 0.0/5—a full 1.92 points below the category average. Users who prioritize streaming audio from their phone should consider alternatives. Own-voice comfort measured 2.7/5, slightly above category average but still mixed in absolute terms. The MatriX features rechargeable batteries and supports streaming from both iPhone and Android devices. With a normalized Initial Score of 3.7/5 improving to 4.3/5 after tuning, this hearing aid responds well to optimization. It's best suited for users who prioritize speech clarity and feedback-free wear over music streaming quality, and who want a budget OTC option that delivers above-average speech performance in our lab framework.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.